Good News For AbbVie: Allergan's Q2 Sales Exceed Expectations, Including Behemoth Botox

 
• By Mandy Jackson

AbbVie is buying Allergan for its product sales, both to increase its own revenues and to fund future R&D and business development, so Allergan's Q2 gains are good news.

Businessman draws a statistical trend line
Q2 Botox sales rose and Restasis held up much better than expected. • Source: Shutterstock

More from Earnings

More from Business